AngioDynamics, Inc.
ANGO
$9.22
$0.111.21%
NASDAQ
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.32% | -1.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.32% | -1.15% | |||
| Cost of Revenue | 14.46% | 0.63% | |||
| Gross Profit | 8.65% | -2.63% | |||
| SG&A Expenses | 1.88% | 0.04% | |||
| Depreciation & Amortization | -0.38% | 1.41% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.53% | 0.95% | |||
| Operating Income | 45.35% | -31.12% | |||
| Income Before Tax | -38.58% | 59.36% | |||
| Income Tax Expenses | -2,900.00% | 98.18% | |||
| Earnings from Continuing Operations | -37.28% | 58.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.28% | 58.96% | |||
| EBIT | 45.35% | -31.12% | |||
| EBITDA | -264.74% | -118.35% | |||
| EPS Basic | -36.79% | 58.88% | |||
| Normalized Basic EPS | -263.25% | 77.48% | |||
| EPS Diluted | -36.64% | 58.08% | |||
| Normalized Diluted EPS | -263.25% | 77.48% | |||
| Average Basic Shares Outstanding | 0.32% | -0.17% | |||
| Average Diluted Shares Outstanding | 0.32% | -0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||